You are here

US FDA warns Indian drugmaker Lupin on repeated quality violations

BT_20171116_NSLUPIN_3178372.jpg
In 2015 and 2016, the FDA found 134 instances when drugs or active ingredients failed initial testing but the firm chose to override the results. Lupin called the failed tests at the plant "laboratory error".

Washington

LUPIN Ltd, which makes generic antibiotics, antidepressants and heart medications for sale in the United States, was warned by the Food and Drug Administration (FDA) for repeatedly ignoring tests showing that pills made at two of its facilities didn't meet quality standards.

sentifi.com

Market voices on:

grab

Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at btsub.sg/promo

Powered by GET.comGetCom